SCHEMBL31489704

SCHEMBL31489704

C[C@H](c1ccc(C(F)(F)F)cc1)n1cc(-c2cccc(-c3ccn4nc(N)nc4c3)c2F)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.39
CREBBP Q92793 3/20 0.38
RIPK1 Q13546 1/20 0.37
PIK3CG P48736 9/20 0.35
PIK3CD O00329 8/20 0.35
BTK Q06187 3/20 0.34
TEC P42680 1/20 0.34
TXK P42681 1/20 0.34
BMX P51813 1/20 0.34
PAK4 O96013 1/20 0.34
JAK1 P23458 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
CSNK1A1 P48729 1/20 0.34
AAK1 Q2M2I8 1/20 0.34
PIP4K2C Q8TBX8 1/20 0.34
CSNK1G1 Q9HCP0 1/20 0.34
NTRK1 P04629 3/20 0.32
CSF1R P07333 3/20 0.32
NTRK2 Q16620 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489611 1.00 JAK2 (0.39) JAK2CREBBPRIPK1PIK3CGPIK3CD
SCHEMBL31489633 0.91 RIPK1 (0.40) CREBBPRIPK1PIK3CGPIK3CDPAK4
SCHEMBL31489701 0.91 RIPK1 (0.40) CREBBPRIPK1PIK3CGPIK3CDPAK4
SCHEMBL31489426 0.90 CREBBP (0.39) JAK2CREBBPRIPK1PIK3CGPIK3CD
SCHEMBL31489190 0.90 CREBBP (0.39) JAK2CREBBPRIPK1PIK3CGPIK3CD
SCHEMBL31489221 0.90 CREBBP (0.47) CREBBPRIPK1PIK3CGPIK3CD
SCHEMBL31489824 0.90 CREBBP (0.47) CREBBPRIPK1PIK3CGPIK3CD
SCHEMBL31489792 0.87 RIPK1 (0.42) CREBBPRIPK1PIK3CGPIK3CDPAK4
SCHEMBL31489674 0.87 RIPK1 (0.42) CREBBPRIPK1PIK3CGPIK3CDPAK4
SCHEMBL31489343 0.87 CREBBP (0.43) JAK2CREBBPRIPK1PIK3CGPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 WO disclosed